A prealbumin activator of prekallikrein: III. appearance of ci-iemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

Journal of Experimental Medicine

Volumn 135, Issue 1, 1972, Pages 81-97

  Kaplan, Allen P ^a   Kay, A B ^a   Austen, K Frank ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; DYFLOS; ENZYME PRECURSOR; KALLIKREIN; KETONE;

ARTICLE; BINDING SITE; BIOSYNTHESIS; BLOOD; CHEMOTAXIS; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; ISOELECTRIC FOCUSING; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

BINDING SITES; BRADYKININ; CHEMOTAXIS; ENZYME ACTIVATION; ENZYME PRECURSORS; FACTOR XII; HUMAN; ISOELECTRIC FOCUSING; ISOFLUROPHATE; KALLIKREINS; KETONES; NEUTROPHILS;

EID: 0015256028     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.135.1.81     Document Type: Article

References (42)

1. Margolis, J. 1957. Plasma pain-producing substance and blood clotting. Nature (London). 180: 1465.
2. Margolis, J. 1958. Activation of a permeability factor in plasma by contact with glass. Nature (London). 181: 635.
3. Webster, M. E., and O. D. Ratnoff. 1961. Role of Hageman factor in the activa tion of vasodilator activity in human plasma. Nature (London). 192: 180.
4. Kaplan, A. P., and K. F. Austen. 1970. A prealbumin activator of prekallikrein. J. Immunol. 802: 91.
5. Kaplan, A. P., and K. F. Austen. 1970. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J. Exp. Med. 133: 696.
6. Webster, M. E., and J. V. Pierce. 1963. The nature of the kallidins released from human plasma by kallikrein and other enzymes. Ann. N. Y. Acad. Sci. 104: 91.
7. Righetti, P. G., and J. W. Drysdale. 1971. Isoelectric focusing in polyacrylamide gels. Biochim. Biophys. Acta. 236: 17.
8. Kaplan, A. P., J. Spragg, and K. F. Austen. The bradykinin forming system in man. In Second International Symposium on the Biochemistry of the Acute Allergic Reactions. K. F. Austen and E. L. Becker, editors. Blackwell Scientific Publications Ltd., Oxford. In press.
9. Rocha E Silva, M., W. T. Beraldo, and G. Rosenfeld. 1949. Bradykinin, hypoten sive and smooth muscle stimulating factor released from plasma globulin by snake venom and by trypsin. Amer. J. Physiol. 156: 261.
10. Talamo, R. C., E. Haber, and K. F. Austen. 1969. A radioimmunoassay for bradykinin in plasma and synovial fluid. J. Lab. Clin. Afed. 74: 816.
11. Jonasson, O., and E. L. Becker. 1966. Release of kallikrein from guinea pig lung during anaphylaxis. J. Exp. Med. 123: 509.
12. Kellermeyer, R. W., and R. T. Breckenridge. 1966. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid. J. Lab. Clin. Med. 67: 455.
13. Kay, A. B. 1970. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea pig serum by antigen-antibody complexes. Clin. Exp. Immunol. 7: 723.
14. Kay, A. B., and K. F. Austen. 1971. The IgE-mediated release of an eosinophil chemotactic factor from human lung. J. Immunol. 107: 899.
15. Kay, A. B. 1969. Eosinophil leucocytes and allergic tissue reactions. Doctorate Thesis. University of Cambridge, England.
16. Lachmann, P. J., A. B. Kay, and R. A. Thompson. 1970. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth, and seventh components of human complement (C567) prepared in free solution by the "reactive lysis" procedure. Immunology. 19: 895.
17. Fahey, J. L., and C. McLaughlin. 1963. Preparation of antisera specific for 6.6 S γ globulins, ßA globulins, 7I macroglobulins, and for Type I and II common γ globulin determinants. J. Immunol. 91: 484.
18. Webster, M. E. 1968. Human plasma kallikrein, its activation and pathological role. Fed. Proc. 27: 84.
19. Kagen, L. G., J. P. Leddy, and E. L. Becker. 1963. Isolation of two permeability globulins from human serum. Nature (London). 197: 693.
20. Schiffman, S., S. I. Rappaport, A. G. Ware, and J. W. Mehl. 1960. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma. Proc. Soc. Exp. Biol. Med. 105: 453.
21. McConnell, D. J., and B. Mason. 1970. The isolation of human prekallikrein. Bril. J. Pharmacol. Chemotker. 38: 490.
22. Ratnoff, O. D., S. W. Davie, and D. L. Mallet. 1961. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J. Clin. Invest. 40: 803.
23. MacFarlane, R. G. 1964. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature (London). 202: 498.
24. Ogston, D., C. M. Ogston, O. D. Ratnoff, and C. D. Forbes. 1969. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J. Clin. Invest. 48: 1786.
25. McDonagh, K. P., and J. H. Ferguson. 1970. Studies on the participation of Hageman factor in fibrinolysis. Thromb. Diath. Haemorrh. 24: 1.
26. Mason, B., and A. A. Miles. 1962. Globulin permeability factors without kinino-genase activity. Nature (London). 196: 587.
27. Lewis, G. P. 1961. Bradykinin. Nature (London). 192: 596.
28. Niewiarowski, S., E. Benkowski, and I. Rogowicka. 1965. Studies in the adsorp tion and activation of Hageman factor (factor XII) by collagen and elastin. Thromb. Diath. Haemorrh. 14: 387.
29. Wilner, G. D., H. L. Nossel, and E. C. LeRoy. 1968. Activation of Hageman factor by collagen. J. Clin. Invest. 47: 2608.
30. Kellermeyer, R. W., and R. T. Breckenridge. 1965. The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals. J. Lab. Clin. Med. 65: 307.
31. Ratnoff, O. D. 1968. Activation of Hageman factor by L-homocystine. Science (Washington). 29: 1007.
32. Moskowitz, R. W., H. J. Schwartz, B. Michel, O. D. Ratnoff, and T. Astrup. 1970. Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: possible pathophysiologic implications. J. Lab. Clin. Med. 76: 790.
33. Ward, P. A. 1967. A plasmin-split fragment of C’3 as a new chemotactic factor. J. Exp. Med. 126: 189.
34. Ward, P. A., and L. J. Newman. 1969. A neutrophil chemotactic factor from human C’5. J. Immunol. 102: 93.
35. Cochrane, C. G., and H. J. Müller-Eberhard. 1968. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. Exp. Med. 127: 371.
36. Budzko, D. B., V. A. Bokisch, and H. J. Müller-Eberhard. 1971. A fragment of the third component of human complement with anaphylatoxin activity. Biochemistry. 10: 1166.
37. Becker, E. L., and P. A. Ward. 1967. Partial biochemical characterization of the activated esterase required in complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes. J. Exp. Med. 125: 1021.
38. Becker, E. L. 1969. Enzymatic mechanisms on complement dependent chemotaxis. Fed. Proc. 28: 1704.
39. Ward, P. A., and E. L. Becker. 1970. Biochemical demonstration of the activatable esterase of the rabbit neutrophil involved in the chemotactic response. J. Immunol. 105: 1057.
40. Balls, A. K., and E. F. Jansen. 1952. Stoichiometric inhibition of chymotrypsin. Advan. Enzymol. 13: 321.
41. Mounter, L. A., and B. A. Shipley. 1958. The inhibition of piasmin by toxic phosphorus compounds. J. Biol. Chem. 231: 855.
42. Wuepper, K., and C. G. Cochrane. Isolation and mechanism of activation of components of the plasma kinin-forming system. In Second International Symposium on the Biochemistry of the Acute Allergic Reactions. K. F. Austen and E. L. Becker, editors. Blackwell Scientific Publications, Ltd., Oxford. In press.